Device Trial Radar · NCT06709261
Safety and Performance of the OTTAVA Robotic System
Last checked: Nov 20, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Feb 5, 2025
Primary completion
Oct 20, 2025
Study completion Oct 20, 2025
Sponsor
- Lead sponsor
- Auris Health, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 29, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study assesses safety and performance of the OTTAVA Robotic System, through 30 days postoperative, in subjects undergoing robotic-assisted Roux-en-Y Gastric Bypass (RYGB) procedure.
Conditions
- Obesity
Interventions
OTTAVA Robotic SystemDevice
Procedure with the OTTAVA Robotic System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedure completion without conversion to open surgeryTime frame: Procedure day
1 more outcomes with a free account
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Orlando Health
Orlando, Florida
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.